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Short Report
Integrative Medicine Research at an Academic Medical
Center: Patient Characteristics and Health-Related 
Quality-of-Life Outcomes
Jeffrey M. Greeson, Ph.D.,1 Steven Rosenzweig, M.D.,2 Steven C. Halbert, M.D.,2 Ira S. Cantor, M.D.,3
Matthew T. Keener, M.D.,4 and George C. Brainard, Ph.D.5,6
Abstract
Objective: To characterize patients seeking care at a university-based integrative medicine practice, and to as-
sess short-term changes in health-related quality of life (HRQoL) associated with integrative medical treatment.
Design: Prospective, observational study.
Setting: This study was conducted at a large U.S. academic medical center affiliated with the Consortium of
Academic Health Centers for Integrative Medicine.
Participants: Seven hundred and sixty-three (763) new patients with diverse medical conditions participated
in the study. Mean age was 49 years (standard deviation  16, range  14–93). Two thirds of patients were
women and three quarters were white. The most common International Classification of Diseases 9th Revision
medical diagnoses were malaise and fatigue, myalgia and myositis, allergy, anxiety or depression, hyperten-
sion, malignant neoplasm of the breast, lumbago, and irritable bowel disease. Over half the sample had two or
more comorbid medical conditions.
Outcome measure: The Medical Outcomes Study 36-item Short-Form (SF-36) health survey was used to mea-
sure HRQoL at initial assessment and 3-months following integrative medicine consultation.
Results: Baseline SF-36 scores fell below the 25th percentile, indicating substantially compromised HRQoL.
Physician-prescribed treatment modalities included anthroposophical medicine, nutritional medicine, Western
herbs, homeopathy, nutritional counseling, and acupuncture. Three (3) month follow-up assessment revealed
statistically significant improvements on all eight SF-36 subscales among survey respondents. HRQoL effect
sizes ranged from 0.17 (Physical Functioning) to 0.41 (Social Functioning), with a mean of 0.30. HRQoL effects
were consistent among demographic subgroups.
Conclusions: Integrative medical treatment at a university-based center is associated with significant increases
in HRQoL for a medically diverse population with substantial comorbidity and functional limitations. Con-
trolled studies that measure HRQoL and additional outcomes related to whole person health—physical, men-
tal, social, and spiritual—are needed to determine the full therapeutic potential of integrative medicine, and to
determine efficacy and cost-effectiveness relative to conventional medical care.
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Introduction
Integrative medicine has been defined as “the practice ofmedicine that reaffirms the importance of the relationship
between practitioner and patient, focuses on the whole per-
son, is informed by evidence, and makes use of all appro-
priate therapeutic approaches, health care professionals and
disciplines to support optimal health and healing.”1 Inte-
grative Medicine is an increasingly popular paradigm of
whole-person health care; however, few empirical data are
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currently available to guide evidence-based practice.2,3 To
better understand the therapeutic effects of integrating con-
ventional allopathic medicine and complementary and al-
ternative medicine (CAM), scientific research institutions in-
cluding the National Institutes of Health Clinical Center and
university-based academic medical centers have initiated ef-
forts to study the efficacy, safety, and cost-effectiveness of
integrative medical treatment.4–6
Observational treatment outcome studies in real-world
health care settings can provide useful information on the
clinical implications of integrating philosophically different
approaches to human health and healing, including (1) what
types of patients present for integrative medical treatment,
(2) whether individualized, integrative approaches to patient
care are associated improved health-related quality of life
(HRQoL), and (3) whether integrative medicine treatment
outcomes generalize across patient demographics and med-
ical conditions.7 Such information can generate hypotheses
for randomized clinical trials (RCTs) designed to definitively
test the efficacy and cost-effectiveness of integrative medi-
cine relative to conventional models of patient care, preven-
tion, and health promotion.
The current study was conducted at a member institution
of the Consortium of Academic Health Centers for Integra-
tive Medicine (CAHCIM) and aimed to (1) medically char-
acterize the presenting patient population, (2) evaluate short-
term changes in HRQoL associated with individualized in-
tegrative medical treatment, and (3) assess differences in
patient-reported outcomes as a function of demographic
characteristics.
Method
A prospective, observational cohort study was conducted
at the Jefferson Center for Integrative Medicine (CIM) of
Thomas Jefferson University and Hospital between Septem-
ber 1998 and June 2001. During this time, all new CIM pa-
tients were invited to participate in an open enrollment treat-
ment outcome study. Patients were not excluded based on
age, gender, ethnicity, socioeconomic status, or medical con-
dition. The clinical research protocol was approved by the
Thomas Jefferson University institutional review board and
all study participants provided informed consent. Patients
less than 18 years of age were enrolled if both parental con-
sent and child assent were obtained.
Demographic data, including age, gender, ethnicity, med-
ical history, and current symptomatic complaints, were col-
lected using an intake evaluation form administered during
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TABLE 1. DEMOGRAPHIC CHARACTERISTICS (N  763)
Mean (SD) N %
Age 49.41 yrs (15.50 yrs) Range 14–93 yrs
14–17 yrs 14 1.8%
18–29 yrs 62 8.2%
30–39 yrs 116 15.2%
40–49 yrs 206 27.0%
50–65 yrs 243 31.8%
66 yrs 122 16.0%
Gender
Women 506 66.3%
Men 223 29.2%
Not reported 34 4.5%
Ethnicity
White 574 75.2%
African-American 55 7.2%
Asian 7 0.9%
Hispanic 5 0.7%
Native American 3 0.4%
Other 5 0.7%
Unknown/not reported 114 14.9%
ICD-9 medical diagnoses
Malaise & fatigue 90 11.8%
Myalgia & myositis 74 9.7%
Allergy 67 8.8%
Anxiety or depression 61 8.0%
Hypertension 46 6.0%
Malignant neoplasm, breast 45 5.9%
Lumbago 39 5.1%
Irritable bowel disease 37 4.8%
Prevalence of comorbidity
No medical diagnosis 34 4.5%
1 medical diagnosis 255 33.4%
2 medical diagnoses 281 36.8%
3 or more medical diagnoses 193 25.3%
ICD-9, International Classification of Diseases, 9th Revision; SD, standard deviation.
the initial office visit. The Medical Outcomes Study 36-item
Short-Form (SF-36), a standardized general health survey that
measures eight scales of HRQoL including physical, mental,
and social functioning,8–10 was completed by all new consent-
ing patients. Medical diagnoses and physician-recommended
treatments were tracked by an electronic billing system.
Patients who completed a baseline SF-36 health survey
were mailed a 3-month follow-up form to assess short-term
HRQoL outcomes. If a follow-up survey response was not
received within 2 weeks, a second mailing was sent. De-
scriptive statistics were generated using all available demo-
graphic, medical, and HRQoL data. Baseline and 3-month
follow-up SF-36 data were analyzed using paired samples t-
tests, 95% confidence intervals and the Standardized Re-
sponse Mean to estimate effect sizes.11 Differences in demo-
graphic characteristics and baseline SF-36 data between
follow-up survey respondents and nonrespondents were
tested using 2 and independent samples t-tests. To deter-
mine whether changes in HRQoL differed as a function of
age, gender, ethnicity, or medical comorbidity status, de-
mographic variables were used to facilitate subgroup analy-
ses of SF-36 change scores. All data are reported as mean 
standard deviation unless otherwise indicated.
Results
Demographic characteristics of the study sample
Table 1 provides a demographic summary of the study
population (n  763; mean age  49  16 years, range 
14–93 years; 66% female; 75% white). Of nearly 250 different
primary medical diagnoses made by CIM physicians, the
most common were: malaise and fatigue, myalgia and
myositis, allergy, anxiety or depression, hypertension, ma-
lignant neoplasm of the breast, lumbago, and irritable bowel
disease. CAM modalities prescribed by CIM physicians in-
cluded anthroposophical medicine, nutritional medicine,
Western herbs, homeopathy, nutritional counseling, and
acupuncture.
Outcome measures and statistical analyses
Mean baseline SF-36 scores fell below the 25th percentile
relative to general U.S. population norms, indicating rela-
tively poor HRQoL at the time of consultation. Nearly half
of new consenting patients (n  370; 48.5%) responded to the
3-month follow-up survey by mail. Median response time
was 19.5  33.9 days. Follow-up survey nonrespondents did
not differ significantly from respondents on SF-36 subscales
at baseline, indicating comparable physical and mental
health status (all p values 0.05). In addition, nonrespon-
dents to the follow-up survey did not differ significantly
from respondents in terms of mean age (t761  0.39, p  0.70),
gender (21  0.12, p  .73), ethnicity (21  2.84, p  0.09),
or medical comorbidity (23  6.05, p  0.11), indicating
comparable demographic characteristics and illness severity.
Comparison of baseline and 3-month follow-up SF-36 data
for 370 survey completers revealed significant changes on all
eight HRQoL subscales (Table 2). Mean effect size was 0.30,
with a range between 0.17 (Physical Functioning) and 0.41
(Social Functioning); these values represented small to
medium effects.12 Six (6) of eight SF-36 subscales improved
five points or more, indicative of clinically relevant change.9
HRQoL outcomes did not differ significantly by age, gender,
ethnic minority status, or medical comorbidity (all p-values
 0.10).
Discussion
This study is the first to describe patient characteristics
and HRQoL treatment outcomes at a university-based inte-
grative medicine clinic in the United States. Consistent with
national survey data on CAM use, three quarters of the pre-
senting patients were white and two thirds of the patients
were female.13–15 Also consistent with national data, patients
presenting for integrative medical care tended to report mul-
tiple medical conditions and relatively poor HRQoL.13–-15
Clinically significant changes on 6 of 8 HRQoL measures
were detected at 3-month follow-up in a medically and de-
mographically representative sample of 370 new patients.
These data indicate that individualized, integrative medical
treatment was associated with meaningful short-term im-
provement in physical, mental, and social functioning
among patients who responded to follow-up assessment.
This study extends previous findings by demonstrating that
patients who seek to integrate CAM with allopathic medi-
cine at a university-based academic medical center practice
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TABLE 2. CHANGES IN HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH INTEGRATIVE MEDICAL TREATMENT (N  370)
Mean Mean 3-month Mean differencea Effect
SF-36 scales (0–100) baseline (SD) follow-up (SD) (95% CI) t-valueb sizec
Physical functioning 70.02 (28.72) 73.04 (28.08) 3.02 (1.73, 5.42) 3.27 0.17
Role limitations, physical 41.24 (41.84) 56.02 (43.67) 14.78 (9.96, 19.47) 6.32 0.33
Bodily pain 53.36 (27.87) 60.70 (28.73) 7.34 (5.36, 10.07) 6.11 0.32
General health perception 57.20 (24.76) 60.78 (24.79) 3.58 (1.65, 5.16) 3.99 0.21
Vitality 42.72 (24.28) 50.90 (24.42) 8.18 (5.81, 10.35) 7.27 0.38
Social functioning 58.98 (29.35) 70.60 (28.81) 11.62 (8.74, 14.67) 7.78 0.41
Role limitations, emotional 60.66 (41.86) 72.68 (39.39) 12.02 (7.17, 16.91) 4.96 0.26
Mental health 63.99 (20.17) 70.17 (19.48) 6.18 (4.21, 8.05) 6.44 0.34
Physical component summary 40.70 (12.29) 43.03 (12.39) 2.33 (1.40, 3.15) 5.24 0.28
Mental component summary 43.56 (11.69) 47.84 (11.29) 4.28 (3.11, 5.51) 6.98 0.38
aPositive difference indicates improvement. Five (5) point change or greater is clinically relevant.9
bAll paired samples t-tested are two-tailed and significant at p  0.001.
cStandardized response mean [mean difference]/[SD of mean difference]; 0.20  small, 0.50  medium, 0.80  large.12
SF, Short Form; SD, standard deviation; CI, confidence interval.
are not simply the “worried well”; rather they are individu-
als with complex health conditions who may benefit signif-
icantly from a whole-person model of care.
Interpretation of results is limited by a nonrandomized
study design, which precludes causal inferences. Although
a direct comparison group was not available in this study,
patient-reported outcomes on the SF-36 were consistent with
those published by three other integrative medicine prac-
tices: one in California, one in Canada, and one in Ger-
many.16–18 A novel finding of this study was that short-term
improvements in HRQoL did not differ significantly as a
function of age group, gender, ethnic minority status, or
medical comorbidity, suggesting that integrative medical
treatment effects were consistent across demographic sub-
groups and different levels of illness severity. Whereas data
were not collected on duration of illness for this study, re-
sults indicated that responders and nonresponders to the fol-
low-up SF-36 survey did not differ significantly on measures
of illness severity, including physical and mental function-
ing and the number of medical conditions diagnosed at base-
line. These findings suggest that individuals who responded
to the follow-up survey were neither healthier nor sicker
compared to patients who did not respond. Collectively, this
investigation and others demonstrate that integrative,
whole-person models of care are associated with clinical ben-
efits among a variety of patients who present with dimin-
ished quality of life.
Future research on Integrative Medicine can build upon
early HRQoL findings. First, observational estimates of treat-
ment effects can be used to statistically power RCTs, which
are needed to compare the relative efficacy, safety, and cost-
effectiveness of Integrative Medicine versus conventional
care for specific medical conditions. Second, given the rela-
tionship-centered focus of Integrative Medicine,19 investiga-
tion of the role patient–provider relationships play in deter-
mining treatment outcomes is essential. Previous research on
family medicine and general internal medicine clinics found
that patients treated by physicians who spent more time
counseling on psychosocial aspects of care, including inter-
personal relationships and emotional well-being, reported
significantly greater improvement in HRQoL, even though
mean HRQoL did not improve significantly following 1 year
of treatment in either specialty.20 Those findings suggest that
mean HRQoL improvements observed at a university-based
Integrative Medicine clinic compare favorably to conven-
tional primary care practices. Although the relative cost-ef-
fectiveness of Integrative Medicine remains unknown, a re-
cent systematic review found that several CAM therapies
appear to be of good health economic value.21
Future clinical studies on Integrative Medicine will bene-
fit from taking an integrative “systems” approach to out-
come assessment.22,23 For instance, concurrent measurement
of biologic, psychologic, social, spiritual, and contextual di-
mensions of whole-person health can help elucidate patterns
of change in medical conditions, risk factors, and/or health
behaviors that occur during integrative medical treatment.
Advanced data analytic methods, such as structural equa-
tion modeling, can be applied to test complex systems of
variables that may involve multiple predictors, mediators,
and outcomes.24 Similarly, mixed-effects models can be ap-
plied to understand sources of variability in Integrative Med-
icine treatment outcome(s) attributable to group-level (e.g.,
gender or ethnicity) and individual-level factors (e.g., symp-
tom severity or patient–provider relationship quality) in a
single model.25
In conclusion, integrative medical treatment at a univer-
sity-based practice is associated with notable improvement
in HRQoL for a variety of patients. Moreover, the degree of
improvement in HRQoL does not appear to differ signifi-
cantly as a function of demographic characteristics, includ-
ing illness severity at the time of initial treatment. Controlled
studies that measure HRQoL and additional outcomes re-
lated to whole-person health—physical, mental, social, and
spiritual—are needed to determine the full therapeutic po-
tential of Integrative Medicine, including efficacy and cost-
effectiveness relative to conventional medical care.
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